Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

Healthcare Biotechnology
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > Pumpers and bashers
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(7)
•••
Post by mmayeron Jun 26, 2018 12:04pm
114 Views
Post# 28230450

Pumpers and bashers

Pumpers and bashersEveryone just stop making noise!

Pumpers, you are pumping the wrong thing. You keep talking about the results in July. Those will simply show that the drug is not poison. The phase 1 trial was not why we had a huge run up... it was the payout from the licensee. What will really drive this stock will be the annoucement that we received a first payment from the licensee. 

Bashers, you will get your short play. Biotech companies are the easiest to short.  

We all win... longs will win and shorts will win. Just don't be the fool who changes plans mid way.



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities